Indications for Non-Invasive Ventilation
Non-invasive ventilation (NIV) is particularly indicated for COPD exacerbations with respiratory acidosis (pH 7.25-7.35), hypercapnic respiratory failure from chest wall deformity or neuromuscular disease, cardiogenic pulmonary edema unresponsive to CPAP, and weaning from invasive ventilation. 1
Primary Indications
Acute Hypercapnic Respiratory Failure
COPD Exacerbations:
- Most established indication: COPD patients with pH <7.35 after initial medical treatment 1
- Optimal range: pH 7.25-7.35 (H+ 45-56 nmol/l) 1
- NIV significantly reduces ICU length of stay, hospitalization duration, and mortality in this population 2
- Below pH 7.25, consider invasive mechanical ventilation; below pH 7.15, invasive ventilation is indicated 3
Neuromuscular and Chest Wall Disorders:
- Hypercapnic respiratory failure secondary to chest wall deformity (scoliosis, thoracoplasty) 1
- Neuromuscular diseases with hypoventilation 1
- This was one of the original applications of NIV and remains highly effective 1
Cardiogenic Pulmonary Edema
- Indicated when unresponsive to CPAP alone 1
- Should be initiated early, even in prehospital and emergency department settings 2
- Use in conjunction with necessary cardiological interventions 2
- Both CPAP and NIV (bilevel positive pressure) are recommended as Grade A evidence 4
Immunocompromised Patients
- Acute respiratory failure in immunocompromised patients 4
- Grade A recommendation to prevent intubation-related complications 4
- Particularly valuable as it avoids ventilator-associated pneumonia risk 5
Ventilator Weaning and Post-Extubation
- Weaning facilitation: Particularly in patients with hypercapnic respiratory failure 1, 4
- Prevention of extubation failure: In patients at risk 2
- Reduces reintubation risk in hypercapnic patients 2
- Should be used for preoxygenation before intubation 2
Secondary Indications
Hypoxemic Respiratory Failure (Limited Role)
- Only for mild to moderate impairment: PaO2/FiO2 >150 mmHg 2
- In this range, no significant advantage over high-flow nasal oxygen 2
- Severe ARDS contraindication: High failure rates (30-50%) and increased mortality, especially with delayed intubation 2, 4
- PaO2/FiO2 <100 mmHg requires invasive ventilation 6
Other Conditions
- Chest trauma patients: Evidence supports use 5
- Palliative care: Reduces dyspnea and improves quality of life, though high-flow nasal oxygen may be more comfortable 2, 4
- Post-operative respiratory failure: Improves outcomes 7
Absolute Contraindications
NIV is NOT indicated in: 1
- Impaired consciousness (Glasgow Coma Score <8) 3
- Severe hypoxemia (particularly PaO2/FiO2 <100 mmHg)
- Copious respiratory secretions
- Imminent respiratory arrest
- Severe respiratory distress requiring immediate intubation
Critical Implementation Points
Common Pitfalls to Avoid:
- Inadequate pressure support: National audits show IPAP is often too low; start at 15 cmH2O but escalate to 20-30 cmH2O within 10-30 minutes 3
- Delayed intubation: Persisting with ineffective NIV increases mortality; if pH remains <7.15 or deteriorates despite NIV, proceed to intubation 3
- Excessive mask leak: Minimize through mask adjustment or type change 3
- Therapeutic nihilism: In the UK, too few patients escalate to invasive ventilation when indicated 3
Essential Monitoring Requirements:
- Close clinical monitoring required, especially in moderate-severe respiratory failure 6
- Regular reassessment for treatment failure 6
- ICU backup must be available for patients who do not improve 1
NIV should never substitute for intubation when invasive ventilation is clearly more appropriate 1. The key is early recognition of failure and timely escalation to avoid the increased mortality associated with delayed intubation.